e-learning
resources
Vienna 2003
Monday 29.09.2003
Mechanisms in allergic asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective effect of chronic opisthorchiasis in asthma
T. A. Evdokimova, L. M. Ogorodova (Tomsk, Russia)
Source:
Annual Congress 2003 - Mechanisms in allergic asthma
Session:
Mechanisms in allergic asthma
Session type:
Thematic Poster Session
Number:
1891
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. A. Evdokimova, L. M. Ogorodova (Tomsk, Russia). Protective effect of chronic opisthorchiasis in asthma. Eur Respir J 2003; 22: Suppl. 45, 1891
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Effects of N-acetylcysteine on asthma exacerbation
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2015; 24: 451-461
Year: 2015
Mechanisms of persistence of
Streptococcus pneumoniae
following treatment of acute exacerbation of chronic bronchitis
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
Application of erdosteine in the treatment of occupational chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Pathogenesis of asthma in children
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
The prevention of virus-induced exacerbation of bronchial asthma in children
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012
Efficacy of montelukast in Indian patients having chronic persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003
Impact of antiviral therapy for acute obstructive bronchitis in preschool children
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004
Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 134s
Year: 2004
Mechanisms of acute and chronic airway infection
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Effects of n acetylcystein on proteinas-inhibitory system with chronic bronchitis
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
Clinico-immunological characteristics of acute and exacerbations of chronic bronchitis in youths
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
Source: Eur Respir J, 50 (2) 1602470; 10.1183/13993003.02470-2016
Year: 2017
Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Role of inhaled antioxidants in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005
Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept